Dermata Receives Patent Approval for Topical Dermal Fillers with Bioneedle Delivery System

Dermata Therapeutics has received a notice of acceptance for an Australian patent application for its topical dermal filler program utilizing its Bioneedle Delivery System. The patent, if issued, would be Dermata's first covering the use of BDS with dermal fillers, expanding its global intellectual property portfolio for BDS programs. BDS allows for topical application of macromolecules like dermal fillers, potentially transforming aesthetic treatments and expanding access, improving patient comfort, and redefining the aesthetic standard of care.